Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.

Vaxart, Inc. (NASDAQ:VXRT), a biotechnology company specializing in the development of oral recombinant vaccines with a market capitalization of approximately $159 million, announced on Monday an ...

Attorney generals from 22 states have filed a lawsuit against the Trump Administration for slashing funding for medical and ...

Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment options.

Scientists at the Institute for Systems Biology (ISB) have uncovered key insights into how T cells—the body's frontline ...

Lawyers and a court sheriff turned up at their flat on Feb 10, but the couple denied them entry. Read more at ...

A musician who made global news as one of the first people to receive a skin cancer vaccine has held a sell-out concert to thank those who helped him. Steve Young, from Stevenage, Hertfordshire, ...